Cargando…

To condition or not condition? Analysing ‘change’ in longitudinal randomised controlled trials

OBJECTIVE: The statistical analysis for a 2-arm randomised controlled trial (RCT) with a baseline outcome followed by a few assessments at fixed follow-up times typically invokes traditional analytic methods (eg, analysis of covariance (ANCOVA), longitudinal data analysis (LDA)). ‘Constrained’ longi...

Descripción completa

Detalles Bibliográficos
Autores principales: Coffman, Cynthia J, Edelman, David, Woolson, Robert F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5223669/
https://www.ncbi.nlm.nih.gov/pubmed/28039292
http://dx.doi.org/10.1136/bmjopen-2016-013096
_version_ 1782493216540459008
author Coffman, Cynthia J
Edelman, David
Woolson, Robert F
author_facet Coffman, Cynthia J
Edelman, David
Woolson, Robert F
author_sort Coffman, Cynthia J
collection PubMed
description OBJECTIVE: The statistical analysis for a 2-arm randomised controlled trial (RCT) with a baseline outcome followed by a few assessments at fixed follow-up times typically invokes traditional analytic methods (eg, analysis of covariance (ANCOVA), longitudinal data analysis (LDA)). ‘Constrained’ longitudinal data analysis (cLDA) is a well-established unconditional technique that constrains means of baseline to be equal between arms. We use an analysis of fasting lipid profiles from the Group Medical Clinics (GMC) longitudinal RCT on patients with diabetes to illustrate applications of ANCOVA, LDA and cLDA to demonstrate theoretical concepts of these methods including the impact of missing data. METHODS: For the analysis of the illustrated example, all models were fit using linear mixed models to participants with only complete data and to participants using all available data. RESULTS: With complete data (n=195), 95% CI coverage are equivalent for ANCOVA and cLDA with an estimated 11.2 mg/dL (95% CI −19.2 to −3.3; p=0.006) lower mean low-density lipoprotein (LDL) cholesterol in GMC compared with usual care. With all available data (n=233), applying the cLDA model yielded an LDL improvement of 8.9 mg/dL (95% CI −16.7 to −1.0; p=0.03) for GMC compared with usual care. The less efficient, LDA analysis yielded an LDL improvement of 7.2 mg/dL (95% CI −17.2 to 2.8; p=0.15) for GMC compared with usual care. CONCLUSIONS: Under reasonable missing data assumptions, cLDA will yield efficient treatment effect estimates and robust inferential statistics. It may be regarded as the method of choice over ANCOVA and LDA.
format Online
Article
Text
id pubmed-5223669
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-52236692017-01-13 To condition or not condition? Analysing ‘change’ in longitudinal randomised controlled trials Coffman, Cynthia J Edelman, David Woolson, Robert F BMJ Open Research Methods OBJECTIVE: The statistical analysis for a 2-arm randomised controlled trial (RCT) with a baseline outcome followed by a few assessments at fixed follow-up times typically invokes traditional analytic methods (eg, analysis of covariance (ANCOVA), longitudinal data analysis (LDA)). ‘Constrained’ longitudinal data analysis (cLDA) is a well-established unconditional technique that constrains means of baseline to be equal between arms. We use an analysis of fasting lipid profiles from the Group Medical Clinics (GMC) longitudinal RCT on patients with diabetes to illustrate applications of ANCOVA, LDA and cLDA to demonstrate theoretical concepts of these methods including the impact of missing data. METHODS: For the analysis of the illustrated example, all models were fit using linear mixed models to participants with only complete data and to participants using all available data. RESULTS: With complete data (n=195), 95% CI coverage are equivalent for ANCOVA and cLDA with an estimated 11.2 mg/dL (95% CI −19.2 to −3.3; p=0.006) lower mean low-density lipoprotein (LDL) cholesterol in GMC compared with usual care. With all available data (n=233), applying the cLDA model yielded an LDL improvement of 8.9 mg/dL (95% CI −16.7 to −1.0; p=0.03) for GMC compared with usual care. The less efficient, LDA analysis yielded an LDL improvement of 7.2 mg/dL (95% CI −17.2 to 2.8; p=0.15) for GMC compared with usual care. CONCLUSIONS: Under reasonable missing data assumptions, cLDA will yield efficient treatment effect estimates and robust inferential statistics. It may be regarded as the method of choice over ANCOVA and LDA. BMJ Publishing Group 2016-12-30 /pmc/articles/PMC5223669/ /pubmed/28039292 http://dx.doi.org/10.1136/bmjopen-2016-013096 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Research Methods
Coffman, Cynthia J
Edelman, David
Woolson, Robert F
To condition or not condition? Analysing ‘change’ in longitudinal randomised controlled trials
title To condition or not condition? Analysing ‘change’ in longitudinal randomised controlled trials
title_full To condition or not condition? Analysing ‘change’ in longitudinal randomised controlled trials
title_fullStr To condition or not condition? Analysing ‘change’ in longitudinal randomised controlled trials
title_full_unstemmed To condition or not condition? Analysing ‘change’ in longitudinal randomised controlled trials
title_short To condition or not condition? Analysing ‘change’ in longitudinal randomised controlled trials
title_sort to condition or not condition? analysing ‘change’ in longitudinal randomised controlled trials
topic Research Methods
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5223669/
https://www.ncbi.nlm.nih.gov/pubmed/28039292
http://dx.doi.org/10.1136/bmjopen-2016-013096
work_keys_str_mv AT coffmancynthiaj toconditionornotconditionanalysingchangeinlongitudinalrandomisedcontrolledtrials
AT edelmandavid toconditionornotconditionanalysingchangeinlongitudinalrandomisedcontrolledtrials
AT woolsonrobertf toconditionornotconditionanalysingchangeinlongitudinalrandomisedcontrolledtrials